Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, April 20, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
6073 POSTS
0 Comments
https://blstimes.com
Life Sciences
Boston Development Group VP Bob Doherty to Speak at Boston Life Sciences, Biotech, Pharma, and Medical Facilities Conference
Life Sciences Times
-
March 23, 2025
0
Pharma
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Mortality, Hospitalizations, and Urgent Heart Failure in Patients with ATTR-CM
Life Sciences Times
-
March 23, 2025
0
Biotech
Novartis Receives Third FDA Approval for Oral Fabhalta – First and Only Treatment Approved for C3 Glomerulopathy
Life Sciences Times
-
March 23, 2025
0
Pharma
Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection
Life Sciences Times
-
March 23, 2025
0
Venture Capital
Venture Capital Fundraising in Healthcare Remains Healthy
Life Sciences Times
-
March 21, 2025
0
Legal
Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards
Life Sciences Times
-
March 21, 2025
0
People on the Move
Cardurion Pharmaceuticals Appoints Karen Lewis as Chief People Officer
Life Sciences Times
-
March 20, 2025
0
Venture Capital
Wheeler Bio Announces Oversubscribed $35M Series, Plans for Expansion and Continued Growth
Life Sciences Times
-
March 20, 2025
0
Biotech
Revvity Expands Alliance with Genomics England
Life Sciences Times
-
March 20, 2025
0
Life Sciences
ABI-LAB Co-Founder Gary Kaufman to Speak at Boston Life Sciences Conference
Life Sciences Times
-
March 20, 2025
0
1
...
20
21
22
...
608
Page 21 of 608
TOP AUTHORS
Life Sciences Times
6073 POSTS
0 Comments
https://blstimes.com
Most Read
Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms
April 18, 2025
$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals
April 18, 2025
Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine
April 18, 2025
Beneath the biotech boom
April 17, 2025